2.660USD-4.66%Mkt Cap: 14.09M USDP/E: —Last update: 2026-06-01
Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycli…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap14.09M USD
Enterprise Value4.90M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-33.56M USD
Revenue/Share—
Last Price2.660 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees17
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS60855D2009
Valuation
P/E (Trailing)—
P/E (Forward)-0.03
PEG—
EV/EBITDA-0.18
EV/Revenue—
P/S—
P/B0.59
EPS (TTM)-16.16
EPS (Forward)-110.50
52W Range
1.7904% of range24.00
52W High24.00 USD
52W Low1.790 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-223.64%
ROA-151.68%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-22.73M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-93.33%
Net Debt-9.99M USD
Net Debt/EBITDA0.37
Balance Sheet
Debt/Equity0.02
Current Ratio1.38
Quick Ratio1.30
Book Value/Sh4.691 USD
Cash/Share1.933 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateFeb 1, 2021
Splits
Last Split1:25
Split DateDec 1, 2025
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)21.00 USD
Target Range10.00 USD – 31.00 USD
# Analysts3
Ownership
Shares Out.5.34M
Float5.29M
Insiders0.83%
Institutions4.40%
Short Interest
Short Ratio2.7d
Short % Float9.98%
Short % Out.9.89%
Shares Short527.79K
Short (prev mo.)138.76K
Technical
SMA 502.405 (+10.6%)
SMA 2006.568 (-59.5%)
Beta1.74
S&P 52W Chg27.94%
Avg Vol (30d)223.53K
Avg Vol (10d)258.74K
Technical Indicators
RSI (14)67.2
MACD0.0517
MACD Signal-0.0095
MACD Hist.+0.0612
BB Upper2.819 USD
BB Middle2.424 USD
BB Lower2.029 USD
BB Width32.59%
ATR (14)0.1793 USD
Vol Ratio (20d)1.33x